BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 28765698)

  • 1. Early radiological assessment of locally advanced pancreatic cancer treated with electrochemotherapy.
    Granata V; Fusco R; Setola SV; Piccirillo M; Leongito M; Palaia R; Granata F; Lastoria S; Izzo F; Petrillo A
    World J Gastroenterol; 2017 Jul; 23(26):4767-4778. PubMed ID: 28765698
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electrochemotherapy in locally advanced pancreatic cancer: Preliminary results.
    Granata V; Fusco R; Piccirillo M; Palaia R; Petrillo A; Lastoria S; Izzo F
    Int J Surg; 2015 Jun; 18():230-6. PubMed ID: 25917204
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diffusion kurtosis imaging and conventional diffusion weighted imaging to assess electrochemotherapy response in locally advanced pancreatic cancer.
    Granata V; Fusco R; Setola SV; Palaia R; Albino V; Piccirillo M; Grimm R; Petrillo A; Izzo F
    Radiol Oncol; 2019 Jan; 53(1):15-24. PubMed ID: 30681974
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Irreversible electroporation of hepatocellular carcinoma: preliminary report on the diagnostic accuracy of magnetic resonance, computer tomography, and contrast-enhanced ultrasound in evaluation of the ablated area.
    Granata V; de Lutio di Castelguidone E; Fusco R; Catalano O; Piccirillo M; Palaia R; Izzo F; Gallipoli AD; Petrillo A
    Radiol Med; 2016 Feb; 121(2):122-31. PubMed ID: 26345332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phase I/II Study: Local Disease Control and Survival in Locally Advanced Pancreatic Cancer Treated with Electrochemotherapy.
    Izzo F; Granata V; Fusco R; D'Alessio V; Petrillo A; Lastoria S; Piccirillo M; Albino V; Belli A; Tafuto S; Avallone A; Patrone R; Palaia R
    J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33810058
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Multicenter Randomized Controlled Prospective Study to Assess Efficacy of Laparoscopic Electrochemotherapy in the Treatment of Locally Advanced Pancreatic Cancer.
    Izzo F; Granata V; Fusco R; D'Alessio V; Petrillo A; Lastoria S; Piccirillo M; Albino V; Belli A; Nasti G; Avallone A; Patrone R; Grassi F; Leongito M; Palaia R
    J Clin Med; 2021 Sep; 10(17):. PubMed ID: 34501459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Using positron emission tomography (PET) response criteria in solid tumours (PERCIST) 1.0 for evaluation of 2'-deoxy-2'-[18F] fluoro-D-glucose-PET/CT scans to predict survival early during treatment of locally advanced non-small cell lung cancer (NSCLC).
    Fledelius J; Khalil AA; Hjorthaug K; Frøkiaer J
    J Med Imaging Radiat Oncol; 2016 Apr; 60(2):231-8. PubMed ID: 26678718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of RECIST, EORTC criteria and PERCIST for evaluation of early response to chemotherapy in patients with non-small-cell lung cancer.
    Shang J; Ling X; Zhang L; Tang Y; Xiao Z; Cheng Y; Guo B; Gong J; Huang L; Xu H
    Eur J Nucl Med Mol Imaging; 2016 Oct; 43(11):1945-53. PubMed ID: 27236466
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Liver metastases from colorectal cancer treated with conventional and antiangiogenetic chemotherapy: evaluation with liver computed tomography perfusion and magnetic resonance diffusion-weighted imaging.
    Anzidei M; Napoli A; Zaccagna F; Cartocci G; Saba L; Menichini G; Cavallo Marincola B; Marotta E; Di Mare L; Catalano C; Passariello R
    J Comput Assist Tomogr; 2011; 35(6):690-6. PubMed ID: 22082538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of response to neoadjuvant chemotherapy for esophageal cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
    Yanagawa M; Tatsumi M; Miyata H; Morii E; Tomiyama N; Watabe T; Isohashi K; Kato H; Shimosegawa E; Yamasaki M; Mori M; Doki Y; Hatazawa J
    J Nucl Med; 2012 Jun; 53(6):872-80. PubMed ID: 22582049
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of the Added Value of Diffusion-Weighted Imaging to Conventional Magnetic Resonance Imaging in Pancreatic Neuroendocrine Tumors and Comparison With 68Ga-DOTANOC Positron Emission Tomography/Computed Tomography.
    Farchione A; Rufini V; Brizi MG; Iacovazzo D; Larghi A; Massara RM; Petrone G; Poscia A; Treglia G; De Marinis L; Giordano A; Rindi G; Bonomo L
    Pancreas; 2016 Mar; 45(3):345-54. PubMed ID: 26418904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TLG-S criteria are superior to both EORTC and PERCIST for predicting outcomes in patients with metastatic lung adenocarcinoma treated with erlotinib.
    Ho KC; Fang YD; Chung HW; Liu YC; Chang JW; Hou MM; Yang CT; Cheng NM; Su TP; Yen TC
    Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2155-2165. PubMed ID: 27260520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of EORTC criteria and PERCIST for PET/CT response evaluation of patients with metastatic colorectal cancer treated with irinotecan and cetuximab.
    Skougaard K; Nielsen D; Jensen BV; Hendel HW
    J Nucl Med; 2013 Jul; 54(7):1026-31. PubMed ID: 23572497
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative Assessment of Pancreatic Cancer with FDG PET/MR Imaging versus FDG PET/CT Plus Contrast-enhanced Multidetector CT: A Prospective Preliminary Study.
    Joo I; Lee JM; Lee DH; Lee ES; Paeng JC; Lee SJ; Jang JY; Kim SW; Ryu JK; Lee KB
    Radiology; 2017 Jan; 282(1):149-159. PubMed ID: 27556273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Operating procedures for electrochemotherapy in bone metastases: Results from a multicenter prospective study on 102 patients.
    Campanacci L; Bianchi G; Cevolani L; Errani C; Ciani G; Facchini G; Spinnato P; Tognù A; Massari L; Cornelis FH; Mosconi M; Screpis D; Benazzo F; Rossi B; Bonicoli E; Fazioli F; Nicolosi M; Boffano M; Piana R; De Terlizzi F; Cadossi M; Donati DM
    Eur J Surg Oncol; 2021 Oct; 47(10):2609-2617. PubMed ID: 34083080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The predictive value of
    Mattoli MV; Massaccesi M; Castelluccia A; Scolozzi V; Mantini G; Calcagni ML
    Radiat Oncol; 2017 Jan; 12(1):4. PubMed ID: 28057034
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intraoperative electrochemotherapy in locally advanced pancreatic cancer: indications, techniques and results-a single-center experience.
    Casadei R; Ricci C; Ingaldi C; Alberici L; Di Marco M; Guido A; Minni F; Serra C
    Updates Surg; 2020 Dec; 72(4):1089-1096. PubMed ID: 32399592
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Value of dual-energy CT-based volumetric iodine-uptake in the evaluation of chemotherapy efficacy in advanced gastric cancer].
    Chen LF; Fu GZ; Huang DP; Man Y; Jin Y; Dong QT; Huang YB; Chen YC; Wang HQ
    Zhonghua Wei Chang Wai Ke Za Zhi; 2019 Oct; 22(10):977-983. PubMed ID: 31630497
    [No Abstract]   [Full Text] [Related]  

  • 19. Correlation between apparent diffusion coefficients on diffusion-weighted MRI and standardized uptake value on FDG-PET/CT in pancreatic adenocarcinoma.
    Sakane M; Tatsumi M; Kim T; Hori M; Onishi H; Nakamoto A; Eguchi H; Nagano H; Wakasa K; Hatazawa J; Tomiyama N
    Acta Radiol; 2015 Sep; 56(9):1034-41. PubMed ID: 25267921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Electrochemotherapy with intravenous bleomycin for advanced non-melanoma skin cancers and for cutaneous and subcutaneous metastases from melanoma.
    Tomassini GM; Covarelli P; Tomassini MA; Corsi A; Bianchi L; Hansel K; Stingeni L
    G Ital Dermatol Venereol; 2016 Oct; 151(5):499-506. PubMed ID: 27595201
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.